Prevalence and clinical characteristics of overactive bladder in systemic sclerosis

References

• Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685–99.
   PubMed Web of Science ®Google Scholar
• Jinnin M. Mechanisms of skin fibrosis in systemic sclerosis. J Dermatol. 2010;37(1):11–25.
   PubMed Web of Science ®Google Scholar
• Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol. 2010;37(1):42–53.
   PubMed Web of Science ®Google Scholar
• Asano Y, Sato S. Vasculopathy in scleroderma. Semin Immunopathol. 2015;37(5):489–500.
   PubMed Web of Science ®Google Scholar
• Motegi S, Toki S, Hattori T, Yamada K, Uchiyama A, Ishikawa O. No association of atherosclerosis with digital ulcers in Japanese patients with systemic sclerosis: evaluation of carotid intima-media thickness and plaque characteristics. J Dermatol. 2014;41(7):604–8.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Okazaki Y, Seta N, Satoh T, Takahashi K, Ikezawa Z, et al. Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis. Arthritis Res Ther. 2010;12(6):R205.
   PubMed Web of Science ®Google Scholar
• Motegi S, Sekiguchi A, Yonemoto Y, Mieda T, Chikuda H, Ishikawa O. Demographic and clinical characteristics of spinal calcinosis in systemic sclerosis: possible association with peripheral angiopathy. J Dermatol. 2019;46(1):33–36.
   PubMed Web of Science ®Google Scholar
• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202–5.
   PubMed Web of Science ®Google Scholar
• Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2007;66(6):754–63.
   PubMed Web of Science ®Google Scholar
• Avouac J, Airò P, Meune C, Beretta L, Dieude P, Caramaschi P, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol. 2010;37(11):2290–8.
   PubMed Web of Science ®Google Scholar
• Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation subcommittee of the international continence society. Neurourol Urodyn. 2002;21(2):167–78.
   PubMed Web of Science ®Google Scholar
• Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4–20.
   PubMed Web of Science ®Google Scholar
• Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–14.
   PubMed Web of Science ®Google Scholar
• Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36.
   PubMed Web of Science ®Google Scholar
• Homma Y, Kakizaki H, Gotoh M, Takei M, Yamanishi T, Hayashi K, et al. Epidemiologic survey on lower urinary tract symptoms in Japan (in Japanese). J Neurogenic Bladder Soc. 2003;14:266–77.
   Google Scholar
• Ninomiya S, Naito K, Nakanishi K, Okayama H. Prevalence and risk factors of urinary incontinence and overactive bladder in Japanese women. Low Urin Tract Sympt. 2018;10(3):308–14.
   PubMed Web of Science ®Google Scholar
• Kucharz EJ, Jonderko G, Rubisz-Brzezinska J, Końca A, Jarczyk R. Premictional volume and contractility of the urinary bladder in patients with systemic sclerosis. Clin Rheumatol. 1996;15(2):118–20.
   PubMed Web of Science ®Google Scholar
• Lazzeri M, Beneforti P, Benaim G, Corsi C, Ciambrone V, Marrapodi E, et al. Vesical dysfunction in systemic sclerosis (scleroderma). J Urol. 1995;153(4):1184–7.
   PubMed Web of Science ®Google Scholar
• Lally EV, Kaplan SR, Susset JG, Trebbin WM, Klutz WS, Cohen SI. Pathologic involvement of the urinary bladder in progressive systemic sclerosis. J Rheumatol. 1985;12(4):778–81.
   PubMed Web of Science ®Google Scholar
• John G, Avouac J, Piantoni S, Polito P, Fredi M, Cozzi F, et al. Prevalence and disease-specific risk factors for lower urinary tract symptoms in systemic sclerosis: an international multicenter study. Arthritis Care Res. 2018;70(8):1218–27.
   Web of Science ®Google Scholar
• John G, Allanore Y, Polito P, Piantoni S, Fredi M, Avouac J, et al. The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study. Rheumatology (Oxford). 2017;56(11):1874–83.
   PubMed Web of Science ®Google Scholar
• van den H, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737–47.
   PubMedGoogle Scholar
• Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, et al. Symptom assessment tool for overactive bladder syndrome: overactive bladder symptom score. Urology. 2006;68(2):318–23.
   PubMed Web of Science ®Google Scholar
• Sanchez K, Denys P, Giuliano F, Palazzo C, Bérezné A, Abid H, et al. Systemic sclerosis: sexual dysfunction and lower urinary tract symptoms in 73 patients. Presse Med. 2016;45(4):e79–89.
   PubMed Web of Science ®Google Scholar
• Turner-Stokes L, Frank AO. Urinary incontinence among patients with arthritis–a neglected disability. J R Soc Med. 1992;85:389–93.
   PubMed Web of Science ®Google Scholar
• Koskimäki J, Hakama M, Huhtala H, Tammela TL. Association of non-urological diseases with lower urinary tract symptoms. Scand J Urol Nephrol. 2001;35(5):377–81.
   PubMedGoogle Scholar
• Hwang R, Chuan F, Peters R, Kuys S. Frequency of urinary incontinence in people with chronic heart failure. Heart Lung. 2013;42(1):26–31.
   PubMed Web of Science ®Google Scholar
• Harris S, Rizzolo D. Botulinum toxin as a treatment for refractory overactive bladder. JAAPA. 2016;29(2):1–4.
   PubMedGoogle Scholar
• Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193(5):1572–80.
   PubMed Web of Science ®Google Scholar
• Motegi S, Yamada K, Toki S, Uchiyama A, Kubota Y, Nakamura T, et al. Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: a prospective, case series study. J Dermatol. 2016;43(1):56–62.
   PubMed Web of Science ®Google Scholar
• Motegi S, Uehara A, Yamada K, Sekiguchi A, Fujiwara C, Toki S, et al. Efficacy of botulinum toxin B injection for Raynaud's phenomenon and digital ulcers in patients with systemic sclerosis. Acta Derm Venereol. 2017;97(7):843–50.
   PubMed Web of Science ®Google Scholar
• Motegi S, Sekiguchi A, Saito S, Ishibuchi H, Kishi C, Yasuda M, et al. Successful treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary. J Dermatol. 2018;45(3):349–52.
   PubMed Web of Science ®Google Scholar